New study aims to unlock secrets of brain tumor survival

NCT ID NCT07162324

Not yet recruiting Knowledge-focused Sponsor: Larissa University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will follow 100 adults with glioblastoma, an aggressive brain cancer, to understand which factors influence survival. Researchers will collect data on patient characteristics, tumor features, surgical methods, and outcomes. The goal is to identify the best surgical strategies for each patient, but no new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors choose better surgical approaches for glioblastoma patients, potentially improving survival and quality of life.
What could go wrong: This is an observational study, not a treatment trial. It will not test a new drug or therapy, so it cannot directly improve outcomes for participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA

Contacts and locations

Locations

Inselspital University Hospital of Bern

Bern, 3010, Switzerland
UCSF Weil Institute for Neurosciences

San Francisco, California, 94143, United States
University Hospital of Larissa

Larissa, Thessaly, 41100, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.